Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Faustini

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Lupus|December 16, 2025
Serological activity in clinically quiescent SLE: To treat or not to treat in the biologic era?Savino Sciascia, Francesca Faustini
Lupus Science & Medicine|May 21, 2020
Could severe COVID-19 be considered a complementopathy?Katerina Chatzidionysiou, Elisabet Svenungsson, Francesca Faustini
Clinical Rheumatology|July 13, 2023
Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort studyLinnea Karlsson, Agneta Zickert, Elisabet Svenungsson, et al.
Clinical and Experimental Immunology|October 8, 2025
Interleukin 16 in lupus nephritis-a role for Th1 and CD8+ T cell migrationKittikorn Wangriatisak, Francesca Faustini, Masa Filipovic, et al.
Rheumatology (Oxford, England)|July 2, 2024
Eculizumab and ravulizumab in the treatment of refractory antiphospholipid syndrome-a first case reportAleksandra Antovic, Francesca Faustini, Natali Karandyszowska, et al.
Arthritis Research & Therapy|August 14, 2021
First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitisFrancesca Faustini, Nicky Dunn, Nastya Kharlamova, et al.
Lupus Science & Medicine|September 14, 2022
Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritisAliisa Häyry, Francesca Faustini, Agneta Zickert, et al.
Frontiers in Immunology|April 25, 2022
Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for ImmunogenicityFrancesca Faustini, Natalie Sippl, Ragnhild Stålesen, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 25, 2009
Rheumatoid leptomeningitis: magnetic resonance imaging and pathologic findings--a case reportAlessandro Cianfoni, Carlo Falcone, Francesca Faustini, et al.
Kidney International Reports|January 15, 2025
Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD EtiologiesCharikleia Chrysostomou, Francesca Faustini, Iva Gunnarsson, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Lupus|December 16, 2025
Serological activity in clinically quiescent SLE: To treat or not to treat in the biologic era?Savino Sciascia, Francesca Faustini
Lupus Science & Medicine|May 21, 2020
Could severe COVID-19 be considered a complementopathy?Katerina Chatzidionysiou, Elisabet Svenungsson, Francesca Faustini
Clinical Rheumatology|July 13, 2023
Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort studyLinnea Karlsson, Agneta Zickert, Elisabet Svenungsson, et al.
Clinical and Experimental Immunology|October 8, 2025
Interleukin 16 in lupus nephritis-a role for Th1 and CD8+ T cell migrationKittikorn Wangriatisak, Francesca Faustini, Masa Filipovic, et al.
Rheumatology (Oxford, England)|July 2, 2024
Eculizumab and ravulizumab in the treatment of refractory antiphospholipid syndrome-a first case reportAleksandra Antovic, Francesca Faustini, Natali Karandyszowska, et al.
Arthritis Research & Therapy|August 14, 2021
First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitisFrancesca Faustini, Nicky Dunn, Nastya Kharlamova, et al.
Lupus Science & Medicine|September 14, 2022
Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritisAliisa Häyry, Francesca Faustini, Agneta Zickert, et al.
Frontiers in Immunology|April 25, 2022
Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for ImmunogenicityFrancesca Faustini, Natalie Sippl, Ragnhild Stålesen, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 25, 2009
Rheumatoid leptomeningitis: magnetic resonance imaging and pathologic findings--a case reportAlessandro Cianfoni, Carlo Falcone, Francesca Faustini, et al.
Kidney International Reports|January 15, 2025
Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD EtiologiesCharikleia Chrysostomou, Francesca Faustini, Iva Gunnarsson, et al.
Pageof 4